Latest Trials Latest NewsFAQ

Oregon Health and Science University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Prospective Clinical Evaluation of the Taperguard Endotracheal Tube

Completed

Conditions: Postoperative Pneumonia

First Posted Date: 2015-05-21

Last Posted Date: 2018-08-21

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 102

Registration Number: NCT02450929

Preterm Infant Inhaled Albuterol Dosing

Phase 4

Completed

Conditions: Bronchopulmonary Dysplasia
Very Low Birth Weight

Interventions: Drug: Varied albuterol dose response

First Posted Date: 2015-05-18

Last Posted Date: 2019-05-23

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 14

Registration Number: NCT02447250

Locations: 🇺🇸
Doernbecher Neonatal Care Center at Oregon Health & Science University, Portland, Oregon, United States

Improving Sleep Quality in People With Insomnia

Not Applicable

Completed

Conditions: Primary Insomnia
Psychophysiological Insomnia

Interventions: Behavioral: Sleep hygiene program
Behavioral: Sleep hypnosis

First Posted Date: 2015-05-14

Last Posted Date: 2016-12-15

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 40

Registration Number: NCT02443649

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Rouxbe Pilot for MS

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Behavioral: Cooking Course

First Posted Date: 2015-04-23

Last Posted Date: 2019-04-29

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 15

Registration Number: NCT02424825

Locations: 🇺🇸
Oregon Health & Science University Multiple Sclerosis Center., Portland, Oregon, United States

Emergency Contraception and Body Weight: Pilot Study

Phase 4

Completed

Conditions: Contraception
Body Weight

Interventions: Drug: ECx1
Drug: ECx2

First Posted Date: 2015-04-03

Last Posted Date: 2017-10-25

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 10

Registration Number: NCT02408692

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid

Phase 2

Conditions: Peripheral Artery Disease

Interventions: Drug: Contrast ultrasound of leg muscle with Sonazoid (Contrast ultrasound microvascular perfusion imaging)

First Posted Date: 2015-03-25

Last Posted Date: 2017-06-19

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 55

Registration Number: NCT02398266

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis

Not Applicable

Completed

Conditions: Psychotic Disorders
Schizophrenia

Interventions: Other: M3 Program
Other: Control

First Posted Date: 2015-03-25

Last Posted Date: 2019-05-28

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 33

Registration Number: NCT02398292

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Acute Microvascular Changes With LDL Apheresis

Completed

Conditions: Hyperlipidemia

Interventions: Procedure: Plasmapharesis

First Posted Date: 2015-03-17

Last Posted Date: 2021-04-01

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 8

Registration Number: NCT02388633

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement

Not Applicable

Completed

Conditions: Psychomotor Agitation
Delirium

Interventions: Other: Acupuncture

First Posted Date: 2015-03-09

Last Posted Date: 2017-01-18

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 100

Registration Number: NCT02383004

Locations: 🇺🇸
Oregon Health & Science University (OHSU), Portland, Oregon, United States

Descemet Endothelial Thickness Comparison Trial

Phase 4

Conditions: Keratoplasty
Grafting, Corneal
Transplantation, Cornea
Keratoplasty, Lamellar
Transplantation, Corneal

Interventions: Procedure: DSAEK
Procedure: DMEK
Device: Endoserter
Drug: Prednisolone
Drug: Ofloxacin
Drug: Tropicamide
Device: Jones Tube
Drug: Phenylephrine

First Posted Date: 2015-02-26

Last Posted Date: 2020-11-25

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 38

Registration Number: NCT02373137

Locations: 🇺🇸
Byers Eye Institute, Stanford University, Palo Alto, California, United States
🇺🇸
F. I. Proctor Foundation, University of California, San Francisco, San Francisco, California, United States
🇺🇸
Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy